LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Nivolumab Has Antitumor Activity in dMMR/MSI-H Colorectal Cancer.

Photo from archive.org

Nivolumab is safe and achieves durable responses in metastatic dMMR/MSI-H colorectal cancer. Click to show full abstract

Nivolumab is safe and achieves durable responses in metastatic dMMR/MSI-H colorectal cancer.

Keywords: cancer; colorectal cancer; msi colorectal; dmmr msi

Journal Title: Cancer discovery
Year Published: 2017

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended


                Click one of the above tabs to view related content.